TGen, INMEGEN to Research Gastric Cancer in Hispanics
The Translational Genomics Research Institute and the Institute of Genomic Medicine in Mexico will research diseases that affect Hispanics. The groups’ first focus will be gastric cancer, the second-leading cause of malignant tumors in Mexico.
Other diseases to be explored include diabetes. TGen said the arrangement with INMEGEN is its first international partnership.
Deltagen Equipment Goes on the Block